These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10501408)

  • 1. Compliance to multiple interventions in a high risk population.
    Pettinger MB; Waclawiw MA; Davis KB; Thomason T; Garg R; Griffin B; Egan DA
    Ann Epidemiol; 1999 Oct; 9(7):408-18. PubMed ID: 10501408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease.
    Garg R; Elam MB; Crouse JR; Davis KB; Kennedy JW; Egan D; Herd JA; Hunninghake DB; Johnson WC; Kostis JB; Sheps DS; Applegate WB
    Am Heart J; 2000 Nov; 140(5):792-803. PubMed ID: 11054628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of the Arterial Disease Multiple Intervention Trial (ADMIT) pilot study.
    Egan DA; Garg R; Wilt TJ; Pettinger MB; Davis KB; Crouse J; Herd JA; Hunninghake DB; Sheps DS; Kostis JB; Probstfield J; Waclawiw MA; Applegate W; Elam MB
    Am J Cardiol; 1999 Feb; 83(4):569-75. PubMed ID: 10073863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.
    Elam MB; Hunninghake DB; Davis KB; Garg R; Johnson C; Egan D; Kostis JB; Sheps DS; Brinton EA
    JAMA; 2000 Sep; 284(10):1263-70. PubMed ID: 10979113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).
    Chesney CM; Elam MB; Herd JA; Davis KB; Garg R; Hunninghake D; Kennedy JW; Applegate WB
    Am Heart J; 2000 Oct; 140(4):631-6. PubMed ID: 11011338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR; Agrawal R; Wunderlich W; Schnitzer L; Stern R; Fischer F; Schultheiss HP
    Am J Cardiol; 2000 Dec; 86(12):1293-8. PubMed ID: 11113401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
    Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA
    Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvastatin with and without niacin for hypercholesterolemia.
    Jacobson TA; Chin MM; Fromell GJ; Jokubaitis LA; Amorosa LF
    Am J Cardiol; 1994 Jul; 74(2):149-54. PubMed ID: 8023779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.
    Belch J; MacCuish A; Campbell I; Cobbe S; Taylor R; Prescott R; Lee R; Bancroft J; MacEwan S; Shepherd J; Macfarlane P; Morris A; Jung R; Kelly C; Connacher A; Peden N; Jamieson A; Matthews D; Leese G; McKnight J; O'Brien I; Semple C; Petrie J; Gordon D; Pringle S; MacWalter R; ; ;
    BMJ; 2008 Oct; 337():a1840. PubMed ID: 18927173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
    Morris R; Robinson G; Tilyard M; Gurr E
    N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of low-dose niacin and pravastatin improves the lipid profile in diabetic patients without compromising glycemic control.
    Gardner SF; Marx MA; White LM; Granberry MC; Skelton DR; Fonseca VA
    Ann Pharmacother; 1997 Jun; 31(6):677-82. PubMed ID: 9184704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis prevention trial: compliance with warfarin treatment and investigation of a retained effect.
    Rudnicka AR; Ashby D; Brennan P; Meade T
    Arch Intern Med; 2003 Jun; 163(12):1454-60. PubMed ID: 12824095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty.
    Wilson AM; Brittenden J; Bachoo P; Ford I; Nixon GF
    J Vasc Surg; 2009 Oct; 50(4):861-9. PubMed ID: 19786240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials.
    WAVE Investigators
    Am Heart J; 2006 Jan; 151(1):1-9. PubMed ID: 16368284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial.
    ; Catalano M; Born G; Peto R
    J Intern Med; 2007 Mar; 261(3):276-84. PubMed ID: 17305650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ginkgo biloba (EGb 761) and aspirin on platelet aggregation and platelet function analysis among older adults at risk of cardiovascular disease: a randomized clinical trial.
    Gardner CD; Zehnder JL; Rigby AJ; Nicholus JR; Farquhar JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):787-93. PubMed ID: 17982321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).
    Ital Heart J; 2000 Dec; 1(12):810-20. PubMed ID: 11302109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.